Impact of the COVID-19 pandemic on HCV elimination in Spain

Buti, Marı́a; Domínguez-Hernández, Raquel

doi:10.1016/j.jhep.2020.12.018

Cited by 26 publications

(35 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…These include the viral hepatitis control program, which, in accordance with the World Health Organization, in 2018, launched a plan to eliminate hepatitis C by 2030. Some countries have already indicated significant impacts on diagnosis of new cases of hepatitis as a result of the COVID-19 pandemic [ 5 , 6 ]. Our objective, therefore, was to analyze the impact of the COVID-19 pandemic on the incidence and number of cases of hepatitis C in Brazil.…”

mentioning

confidence: 99%

Impact of the COVID-19 pandemic on hepatitis C diagnosis in Brazil: Is the global hepatitis C elimination strategy at risk?

Carmo

Souza

2022

Journal of Hepatology

View full text Add to dashboard Cite

mentioning

confidence: 99%

Impact of the COVID-19 pandemic on hepatitis C diagnosis in Brazil: Is the global hepatitis C elimination strategy at risk?

Carmo

Souza

2022

Journal of Hepatology

View full text Add to dashboard Cite

“…This will directly hinder the elimination targets initially proposed by WHO (12). The impact of such a delay and the importance of reactivating and prioritising elimination efforts have also been highlighted by many national studies (13,18).…”

Section: Discussionmentioning

confidence: 99%

“…Being aware of these data is relevant as a delayed diagnosis will increase cases of hepatocarcinoma and liver disease-related death in the next 10 years (12). Likewise, a Markov model with Spanish data has estimated the same results (13). Furthermore, the pandemic has likely led to an uneven diagnostic delay across risk groups and diagnostic strategies (centralised vs. decentralised), that must be corrected accordingly.…”

Section: Introductionmentioning

confidence: 92%

Hepatitis C diagnosis slowdown in high-prevalence groups and using decentralised diagnostic strategies during the COVID-19 pandemic

Morales-Arráez¹,

Benítez-Zafra²,

Díaz‐Flores³

et al. 2022

Rev Esp Enferm Dig

View full text Add to dashboard Cite

D.M.A contributed to data collection, database generation, statistical analysis, writing and editing of the manuscript. F.B.Z assisted with data collection and database generation. F.D.F assisted with data collection from the laboratory and sample analysis. M.J.M.A, L.G.S and V.P.P. contributed to the screening and sample collection from the drug treatment centres. F.G.N collaborated with the analysis of the samples. M.H.G. contributed to the project design, coordination and final review and manuscript approval.

show abstract

“…In fact, the major effect of COVID-19 is the impact in HCV elimination efforts. A Spanish study showed that the interruption of HCV screening, linkage to care and harm reduction programs, would substantially decrease HCV diagnosis and treatment, consequently, increase the number of HCV liver-related deaths, hepatocellular carcinoma (HCC) and decompensated cirrhosis[ 50 ]. Thus, it is of paramount importance to keep HCV elimination a major health priority through innovative programs as telehealth or home-delivery HCV drugs[ 50 ].…”

Section: Covid-19 and Liver Diseasesmentioning

confidence: 99%

Liver and COVID-19: From care of patients with liver diseases to liver injury

Gaspar

Branco

Macedo

2021

WJH

View full text Add to dashboard Cite

The global pandemic of coronavirus disease 2019 (COVID-19) changed dramatically all priorities on medical society and created several challenges for clinicians caring for patients with liver diseases. We performed a comprehensive review about how COVID-19 can affect the liver, the influence of liver diseases on the risk of developing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19 severity and also some strategies to overcome all the challenges clinicians have to face in the management of patients with liver diseases in a period of time when all the focus turned on COVID-19. We analyze the relationship between COVID-19 and non-alcoholic fatty liver disease, alcoholic liver disease, viral hepatitis, autoimmune liver disease, cirrhosis, hepatocellular carcinoma and liver transplantation, as well as the approach to SARS-CoV-2 vaccination.

show abstract

Impact of the COVID-19 pandemic on HCV elimination in Spain

Cited by 26 publications

References 4 publications

Impact of the COVID-19 pandemic on hepatitis C diagnosis in Brazil: Is the global hepatitis C elimination strategy at risk?

Impact of the COVID-19 pandemic on hepatitis C diagnosis in Brazil: Is the global hepatitis C elimination strategy at risk?

Hepatitis C diagnosis slowdown in high-prevalence groups and using decentralised diagnostic strategies during the COVID-19 pandemic

Liver and COVID-19: From care of patients with liver diseases to liver injury

Contact Info

Product

Resources

About